These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 28455524)

  • 21. Craniofacial and dental development in Costello syndrome.
    Goodwin AF; Oberoi S; Landan M; Charles C; Massie JC; Fairley C; Rauen KA; Klein OD
    Am J Med Genet A; 2014 Jun; 164A(6):1425-30. PubMed ID: 24668879
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aberrant HRAS transcript processing underlies a distinctive phenotype within the RASopathy clinical spectrum.
    Pantaleoni F; Lev D; Cirstea IC; Motta M; Lepri FR; Bottero L; Cecchetti S; Linger I; Paolacci S; Flex E; Novelli A; Carè A; Ahmadian MR; Stellacci E; Tartaglia M
    Hum Mutat; 2017 Jul; 38(7):798-804. PubMed ID: 28390077
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comprehensive genetic analysis of overlapping syndromes of RAS/RAF/MEK/ERK pathway.
    Tumurkhuu M; Saitoh M; Sato A; Takahashi K; Mimaki M; Takita J; Takeshita K; Hama T; Oka A; Mizuguchi M
    Pediatr Int; 2010 Aug; 52(4):557-62. PubMed ID: 20030748
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Costello syndrome: Clinical phenotype, genotype, and management guidelines.
    Gripp KW; Morse LA; Axelrad M; Chatfield KC; Chidekel A; Dobyns W; Doyle D; Kerr B; Lin AE; Schwartz DD; Sibbles BJ; Siegel D; Shankar SP; Stevenson DA; Thacker MM; Weaver KN; White SM; Rauen KA
    Am J Med Genet A; 2019 Sep; 179(9):1725-1744. PubMed ID: 31222966
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Two cases with severe lethal course of Costello syndrome associated with HRAS p.G12C and p.G12D.
    Lorenz S; Petersen C; Kordaß U; Seidel H; Zenker M; Kutsche K
    Eur J Med Genet; 2012 Nov; 55(11):615-9. PubMed ID: 22926243
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Decreased bone mineral density in Costello syndrome.
    Leoni C; Stevenson DA; Martini L; De Sanctis R; Mascolo G; Pantaleoni F; De Santis S; La Torraca I; Persichilli S; Caradonna P; Tartaglia M; Zampino G
    Mol Genet Metab; 2014 Jan; 111(1):41-5. PubMed ID: 24246682
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The novel duplication HRAS c.186_206dup p.(Glu62_Arg68dup): clinical and functional aspects.
    Gripp KW; Baker L; Robbins KM; Stabley DL; Bellus GA; Kolbe V; Nauth T; Rosenberger G
    Eur J Hum Genet; 2020 Nov; 28(11):1548-1554. PubMed ID: 32499600
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Attenuated phenotype of Costello syndrome and early death in a patient with an HRAS mutation (c.179G>T; p.Gly60Val) affecting signalling dynamics.
    Gripp KW; Kolbe V; Brandenstein LI; Rosenberger G
    Clin Genet; 2017 Sep; 92(3):332-337. PubMed ID: 28139825
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mice with an Oncogenic HRAS Mutation are Resistant to High-Fat Diet-Induced Obesity and Exhibit Impaired Hepatic Energy Homeostasis.
    Oba D; Inoue SI; Miyagawa-Tomita S; Nakashima Y; Niihori T; Yamaguchi S; Matsubara Y; Aoki Y
    EBioMedicine; 2018 Jan; 27():138-150. PubMed ID: 29254681
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mutant Hras(G12V) and Kras(G12D) have overlapping, but non-identical effects on hepatocyte growth and transformation frequency in transgenic mice.
    Figueiredo ML; Stein TJ; Jochem A; Sandgren EP
    Liver Int; 2012 Apr; 32(4):582-91. PubMed ID: 22221894
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel patient with an attenuated Costello syndrome phenotype due to an HRAS mutation affecting codon 146-Literature review and update.
    Chiu AT; Leung GK; Chu YW; Gripp KW; Chung BH
    Am J Med Genet A; 2017 Apr; 173(4):1109-1114. PubMed ID: 28328122
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oncogenic HRAS mutations cause prolonged PI3K signaling in response to epidermal growth factor in fibroblasts of patients with Costello syndrome.
    Rosenberger G; Meien S; Kutsche K
    Hum Mutat; 2009 Mar; 30(3):352-62. PubMed ID: 19035362
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardio-facio-cutaneous and Noonan syndromes due to mutations in the RAS/MAPK signalling pathway: genotype-phenotype relationships and overlap with Costello syndrome.
    Nava C; Hanna N; Michot C; Pereira S; Pouvreau N; Niihori T; Aoki Y; Matsubara Y; Arveiler B; Lacombe D; Pasmant E; Parfait B; Baumann C; Héron D; Sigaudy S; Toutain A; Rio M; Goldenberg A; Leheup B; Verloes A; Cavé H
    J Med Genet; 2007 Dec; 44(12):763-71. PubMed ID: 17704260
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Costello syndrome and related disorders.
    Quezada E; Gripp KW
    Curr Opin Pediatr; 2007 Dec; 19(6):636-44. PubMed ID: 18025929
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical and molecular characterization of children with Noonan syndrome and other RASopathies in Argentina.
    Chinton J; Huckstadt V; Moresco A; Gravina LP; Obregon MG
    Arch Argent Pediatr; 2019 Oct; 117(5):330-337. PubMed ID: 31560489
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuron type-specific expression of a mutant KRAS impairs hippocampal-dependent learning and memory.
    Ryu HH; Kang M; Hwang KD; Jang HB; Kim SJ; Lee YS
    Sci Rep; 2020 Oct; 10(1):17730. PubMed ID: 33082413
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Duplications in the G3 domain or switch II region in HRAS identified in patients with Costello syndrome.
    Nagai K; Niihori T; Okamoto N; Kondo A; Suga K; Ohhira T; Hayabuchi Y; Homma Y; Nakagawa R; Ifuku T; Abe T; Mizuguchi T; Matsumoto N; Aoki Y
    Hum Mutat; 2022 Jan; 43(1):3-15. PubMed ID: 34618388
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Retinal dystrophy in two boys with Costello syndrome due to the HRAS p.Gly13Cys mutation.
    Pierpont ME; Richards M; Engel WK; Mendelsohn NJ; Summers CG
    Am J Med Genet A; 2017 May; 173(5):1342-1347. PubMed ID: 28337834
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fetal costello syndrome with neuromuscular spindles excess and p.Gly12Val HRAS mutation.
    Quélin C; Loget P; Rozel C; D'Hervé D; Fradin M; Demurger F; Odent S; Pasquier L; Cavé H; Marcorelles P
    Eur J Med Genet; 2017 Jul; 60(7):395-398. PubMed ID: 28455154
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical and molecular analysis of RASopathies in a group of Turkish patients.
    Şimşek-Kiper PÖ; Alanay Y; Gülhan B; Lissewski C; Türkyilmaz D; Alehan D; Cetin M; Utine GE; Zenker M; Boduroğlu K
    Clin Genet; 2013 Feb; 83(2):181-6. PubMed ID: 22420426
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.